Business Context and Reporting Period
This Form 8-K Current Report, dated November 21, 2019, announces the completion of a merger by Glaukos Corporation (GKOS). On this date, Glaukos acquired Avedro, Inc. through a merger with its wholly-owned subsidiary, Atlantic Merger Sub, Inc. Avedro continues as a wholly-owned subsidiary of Glaukos.
Key Financial Metrics
This filing is a current report regarding a corporate transaction and does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity for the reporting period. The document states that required financial statements of the acquired business and pro forma financial information will be filed in an amendment within 71 calendar days.
Material Changes
The primary material change is the consummation of the acquisition of Avedro, Inc. Key transaction terms include:
- Exchange Ratio: Each outstanding share of Avedro common stock was converted into the right to receive 0.365 shares of Glaukos common stock.
- Equity Awards: Outstanding Avedro stock options and restricted stock units (RSUs) were assumed by Glaukos and converted into equivalent Glaukos awards based on the exchange ratio.
- Warrants: Outstanding Avedro warrants were cancelled and converted into Glaukos common stock based on a formula involving the exchange ratio and the volume-weighted average trading price of Glaukos stock.
Guidance, Outlook, and Risks
Management Commentary: The filing references a joint press release (Exhibit 99.1) announcing the completion of the merger but does not contain detailed management commentary or forward-looking guidance within the text of this report.
Contingencies and Unusual Items: The filing notes that financial statements for Avedro and pro forma financial information are pending and will be submitted in a future amendment. No specific risks or unusual items are detailed in this summary text beyond the standard transaction mechanics.
Investor Verification Checklist
- Verify the final Exchange Ratio of 0.365 and its impact on share count dilution.
- Monitor the upcoming amendment to this 8-K (due within 71 days) for pro forma financial information and Avedro's standalone financial statements.
- Review the Joint Press Release (Exhibit 99.1) for strategic rationale and immediate market reaction.
- Confirm the treatment of outstanding warrants and the specific calculation used for their conversion into Glaukos stock.